Spring, 2014

Collaboration Yields New Potential Options for Attacking Stem Cells in Triple-Negative Breast Cancer

New research from the U-M Comprehensive Cancer Center and Georgia Regents University finds that a protein that fuels an inflammatory pathway does not turn off in breast cancer, resulting in an increase in cancer stem cells. This provides a potential target for treating triple negative breast cancer, the most aggressive form of the disease.